BRCA2 and urinary bladder neoplasm: Indeed, analyses of TCGA datasets of ovarian and bladder tumors indicated that MED12 expression levels can stratify the survival of patients with BRCA2-mutant tumors: low MED12 levels trended towards reduced survival of these patients, while high MED12 levels trended towards increased survival.